A small survey of literature about Vitamin D and inhibition and expression of interleukins and tumor necrosis factors. Could Vitamin D have a possible role in Covid-19 Cytokine Release Syndrome? A study of its role when tocilizumab is used exists, and therefore Vitamin D could be considered when tocilizumab is involved in the mitigation of the cytokine storm. However, another question also exists and it is the following. Might Vitamin D induce antimicrobial peptides to reduce SARS-CoV-2 replication?
Vitamin D for Covid-19? / Sparavigna, Amelia Carolina. - ELETTRONICO. - (2020). [10.5281/zenodo.3822187]
Vitamin D for Covid-19?
Amelia Carolina Sparavigna
2020
Abstract
A small survey of literature about Vitamin D and inhibition and expression of interleukins and tumor necrosis factors. Could Vitamin D have a possible role in Covid-19 Cytokine Release Syndrome? A study of its role when tocilizumab is used exists, and therefore Vitamin D could be considered when tocilizumab is involved in the mitigation of the cytokine storm. However, another question also exists and it is the following. Might Vitamin D induce antimicrobial peptides to reduce SARS-CoV-2 replication?File in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
vitamin-D.pdf
accesso aperto
Tipologia:
2a Post-print versione editoriale / Version of Record
Licenza:
Creative commons
Dimensione
126.59 kB
Formato
Adobe PDF
|
126.59 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
Utilizza questo identificativo per citare o creare un link a questo documento:
https://hdl.handle.net/11583/2822997